Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.

Long-term effects of Artiflex implantation in Saudi Arabia

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Interactive Free Paper Session: Anterior chamber phakic IOLS

Session Date/Time: Tuesday 16/09/2014 | 16:30-18:00

Paper Time: 16:54

Venue: Auditorium

First Author: : K.Abdelaty SAUDI ARABIA

Co Author(s): :                  

Abstract Details


To investigate the long term effects in relation to the efficiency and stability of Artiflex Implantation in a four-year period.


Magrabi Riyadh Center, Saudi Arabia


This study takes the account of 22 Saudi patients, 12 females and 10 males of 18-39 years of age with mean of 26 years; inclusive of 40 eyes, 21 OD and 19 OS. All were diagnosed as having High Myopia with pre-operative UDVA range of CF3M to 20/100 with mean of 20/500; and BCVA range of 20/70 to 20/20 with mean of 20/25. Pachymety ranged from 478µm to 631µm, mean of 529.75µm. Simulated keratomety ranged from steepest of 47.61 to 40.40D and to flattest of 45.4D to 33.92D. Mean endothelial cell count was 2445.67 + 404.19.


All were uneventful surgeries and were monitored for visual acuity and endothelial cell count variations. Visits were pre-arranged at 6, 12, 24, 36 and 48 months post-op. A mean of 20/31 UDVA and 20/22 BCVA were achieved in a four year follow-up. Mean endothelial cell count in the whole 4-year post operative period was 2345.36 + 78.240.


Artiflex Implantation manifests stable results in terms of visual improvement. A 4.28% decrease in the endothelial cell count was seen after 4 years.

Financial Interest:


Back to previous